ESTRO 2020 Abstract book

Symposium MR-guided Radiotherapy: state of the art and future perspectives ................................................................................ (Abs. 132-134) Hypoxia-activated prodrugs: is there a future? .................................................................................................................. (Abs. 135-138) Multimodal approaches in oligometastatic prostate disease: state-of-the-art .............................................................. (Abs. 139-142) Debate This house believes that hippocampus avoiding whole brain irradiation is the current standard of care ................ (Abs. 143-146) Symposium Surface guided radiation therapy ........................................................................................................................................ (Abs. 147-149) “Big data” approaches to quality improvement ................................................................................................................. (Abs. 150-152) Radiotherapy: it´s all about the heart ................................................................................................................................. (Abs. 153-155) Poster Highlights Poster highlights 5 CL : GI ..................................................................................................................................................... (Abs. 156-162) Poster highlights 6 RTT: Optimising techniques for breast and H&N RT ........................................................................ (Abs. 163-169) Poster discussion CL: CNS .................................................................................................................................................................................... (Abs. 170-175) CL: Breast 1 ............................................................................................................................................................................. (Abs. 176-181) PH: Dose measurement and dose calculation ................................................................................................................... (Abs. 182-187) PH: Treatment planning: applications 1 .............................................................................................................................. (Abs. 189-193) Award Lecture E. van der Schueren Award Lecture .....................................................................................................................................(Abs. 194) Jens Overgaard Legacy Award .............................................................................................................................................. (Abs. 195) Proffered Papers Proffered papers 8: Cardiac toxicity .................................................................................................................................... (Abs. 196-201) Proffered papers 9: Radiation effects on stem cells and the microenvironment .......................................................... (Abs. 202-207) Proffered papers 10: Prostate .............................................................................................................................................. (Abs. 208-213) Proffered papers 11: Dose calculation for advanced techniques .................................................................................... (Abs. 214-219) Proffered papers 12: Artificial Intelligence and automation ............................................................................................ (Abs. 220-225) Proffered papers 13: Lung .................................................................................................................................................... (Abs. 226-231) Poster Highlights Poster highlights 7 RB: Novel radiobiological targets ........................................................................................................(Abs. 232-237) Poster highlights 8 PH: Planning and validation of ion beams .........................................................................................(Abs. 238-244) Teaching Lecture How can Artificial Intelligence improve contouring? ...................................................................................................... (Abs. 245) How does radiotherapy change the tumour ecosystem ............................................................................................... (Abs. 246) Oligometastatic cancer scenarios: from biology to treatments .................................................................................... (Abs. 247) Bladder conservation strategies ....................................................................................................................................... (Abs. 248) Radiosurgery: potential and pitfalls .................................................................................................................................... (Abs. 249) Dose calculation in external beam radiotherapy: The radiation transport equation and dose-to-water vs. dose-to-medium issues ................................................................................................................................................. (Abs. 250) Patient empowerment in radiotherapy ............................................................................................................................ (Abs. 251) Joint Symposium ESTRO-ASTRO: Patient reported outcomes in radiation oncology - time to make them mandatory in clinical practice? .............................................................................................................................................................. (Abs. 252-255) Symposium Emerging links between radiation-induced anti-tumor immune effects and DNA damage repair signaling ......... (Abs. 256-259) DAY 2